2014 Survey on Living with Chronic Diseases
in Canada (SLCDC): Mood & Anxiety Disorders
National Mental Health and Addictions Information Collaborative
Monday, November 3rd, 2014
Outline
• Background on the SLCDC
» Overview, previous surveys and products
•
2014 SLCDC Mood & Anxiety Disorders
»
»
»
»
»
»
»
»
2
Objectives
Target population (CCHS screening question)
Sampling methods
Sample limitations
Survey content
Public health relevance
Data access
PHAC’s analytical plans and potential products
Overview of the SLCDC
• Survey sponsored and developed by Public Health Agency of Canada
in collaboration with Statistics Canada and expert group.
• Collects information related to the experiences of Canadians with
chronic health conditions.
• 20 minute cross sectional survey, follow-up to CCHS.
• Every 2 years, 1 to 2 chronic disease covered in each cycle:
• 2009 - Hypertension & Arthritis
• 2011 - Diabetes & Respiratory Disease
• 2012 - Neurological conditions
• 2014 - Mood & Anxiety Disorders
3
Previous SLCDC products
•
•
•
•
4
PHAC fact sheets
Peer-reviewed articles
PHAC website (e.g., data cubes)
PHAC internal official statistics
2014 SLCDC: Mood & Anxiety Disorders
Objectives
1. To identify factors which influence mental health/illness outcomes;
2. To assess the impacts of mood & anxiety disorders on Canadians
adults; and
3. To provide more information on how people with mood &/or anxiety
disorders manage their condition and to identify the barriers to
care/self-management.
*Final data file also includes linked responses from the 2013 CCHS (e.g.,
health determinants and co-morbidities) for those who agreed to link and share
with Statistics Canada’s share partners.
5
2014 SLCDC: Mood & Anxiety Disorders
Public health relevance
The SLCDC data can be used by:
» Governments and other stakeholders to better plan and
provide health services for persons with mood & anxiety
disorders and to develop public education campaigns
primarily aimed at health promotion and disease
prevention; and
» Researchers to analyze and report on factors affecting,
impacts and management of mood & anxiety disorders.
6
2014 SLCDC: Mood &/or Anxiety Disorders
Target population
• To be identified from the 2013 CCHS
» Respondents age 18+ (as of December 31st, 2013) with a mood
and/or an anxiety disorder living in privately occupied dwellings
in the ten provinces.
• Excluded (represents < 3% overall Canadian population)
»
»
»
»
7
Persons living on reserves and other Aboriginal settlements;
Persons living in institutions and certain remote regions of QC;
Full-time members of the Canadian Forces; and
Territories.
2014 SLCDC: Mood & Anxiety Disorders
CCHS screening question
Now I’d like to ask about certain chronic health conditions which you may
have. We are interested in “long-term conditions” which are expected to
last or have already lasted 6 months or more and that have been
diagnosed by a health professional.
• Do you have a mood disorder such as depression, bipolar disorder, mania
or dysthmia? Yes/No
• Do you have an anxiety disorder such as a phobia, obsessive compulsive
disorder or a panic disorder? Yes/No
8
2014 SLCDC: Mood & Anxiety Disorders
Sampling methods
9
2014 SLCDC: Mood & Anxiety Disorders
Sample (n=3,361)
•
Should provide reliable estimates at national level for:
» Overall: indicators with min prevalence of ~3%
» By sex: indicators with min prevalence of ~4 to 8%
» By age groups (18-34, 35-49, 50-64 and 65+) with min prevalence of
~8 to 12%
• Should provide reliable regional estimates for indicators with
higher prevalence ~7-18%
• Atlantic, QC, ON, Prairies, BC
• Limitations:
» Sample size limits analyses by age and sex (especially males)
» Sample size limits provincial estimates
10
2014 SLCDC: Mood & Anxiety Disorders
Content
1. General health
2. Confirmation of diagnosis
3. Medication use
4. Self-management
5. Contact with health
professionals
6. Clinical recommendations
7. Restriction of activities
8. Restriction of work activities
9. Sleep
10. Stress
11. Social Provisions Scale
Survey questions were designed for computer-assisted interviewing
(CAI) conducted by telephone.
11
2014 SLCDC: Mood & Anxiety Disorders
Data availability
• Official released
» October 30th, 2014
• Access to data:
» PHAC - DCAP and DAIS
» Public - Statistics Canada’s Research Data Centres (RDC)
12
2014 SLCDC: Mood & Anxiety Disorders
Potential products
»
»
»
»
13
PHAC fact sheet (underway)
Peer-reviewed articles (double theme issue in CDIC Spring 2016)
PHAC website (e.g., data cubes)
PHAC internal official statistics
2014 SLCDC: Mood & Anxiety Disorders
Analytic plans for peer-reviewed articles
• Analyst from the Agency’s Surveillance & Epidemiology
Division (ACDC Section) to develop analytic plans in
collaboration with:
» Internal stakeholders e.g., Social Determinants and Science
Integration Directorate, Centre for Health Promotion (Division of
Children, Seniors and Healthy Development), Centre for Chronic
Disease Prevention (Surveillance & Epidemiology Division,
BELT Section).
» External stakeholders e.g., PHAC’s Mental Health/Mental Illness
Advisory Committee, others?
14
2014 SLCDC: Mood & Anxiety Disorders
Potential topics
•
•
•
•
•
•
Time to diagnosis
Co-morbidities
Impacts
Sleep
Predictors of well being
Concordance between clinical recommendations &
medication use, counselling and physical activity
All analysis will examine key factors that influence health status such
as age, sex, education, income, Aboriginal status etc.
15
2014 SLCDC: Mood & Anxiety Disorders
For more information about this survey:
» Statistics Canada:
http://www23.statcan.gc.ca/imdb/p2SV.pl?Function=getSurvey&SDDS=5160
16